Address
Astellas Venture Management LLC
PO Box 7585
Menlo Park, CA 94026
United States
Website
Recent investment activity
KANDO id: 2625
Corporate information
Official name
Astellas Venture Management LLC
Registration country
Funding rounds
Investment preferences
Actual initial investment stage
Series B (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 32| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
DecImmune Therapeutics Inc | Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction | N/A | |||
|
|
IRX Therapeutics Inc | N/A | ||||
|
|
Cleave Biosciences Inc | Drug development company focused on novel targets in cellular protein homeostasis pathways | Series A | |||
|
|
PhaseBio Pharmaceuticals Inc | N/A | ||||
|
|
Adhelex Technologies | N/A | ||||
|
|
Prolysis Ltd | N/A | ||||
|
|
Cytomyx Holdings PLC | N/A | ||||
|
|
Memory Pharmaceuticals Corp | N/A | ||||
|
|
EPIX Pharmaceuticals Inc | N/A | ||||
|
|
AkaRx Inc | N/A | ||||
|
|
Intradigm Corp | N/A | ||||
|
|
Revivicor Inc | N/A | ||||
|
|
Renovar Inc | N/A | ||||
|
|
PhysioGenix Inc | N/A | ||||
|
|
Neuronautics Inc | N/A | ||||
|
|
FASgen Inc | N/A | ||||
|
|
Ception Therapeutics Inc | Ception Therapeutics, Inc. is an emerging biopharmaceutical company. | N/A | |||
|
|
Epizyme Inc | Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs). | N/A | |||
|
|
F2G Ltd | N/A | ||||
|
|
Inimex Pharmaceuticals Inc | N/A | ||||
|
|
Lectus Therapeutics Ltd | N/A | ||||
|
|
Nereus Pharmaceuticals Inc | Series D | ||||
|
|
Viamet Pharmaceuticals Inc | N/A | ||||
|
|
Cellzome AG | A drug discovery and development company and a leader in the use of chemical proteomics technologies. | N/A | |||
|
|
Evolva Holding SA | N/A |